“Microdosing” psychedelics, taking sub-perceptual doses of substances like LSD or psilocybin, has gone from fringe experimentation to mainstream obsession. Advocates claim benefits such as enhanced creativity, improved mood, increased focus, and relief from depression and anxiety.
Recent clinical trials fail to confirm the hype, at least pharmacologically, and suggest these benefits might not stem from the substances themselves.
Instead, they may be driven by belief. The more rigorous studies indicate that microdosing’s effects could be comparable to those of a placebo.
The “Citizen Science” Origin Story
Psychologist James Fadiman, who began studying psychedelics in the early 1960s, ignited the modern microdosing movement by collecting thousands of self-reported experiences starting in the early 2010s. Focusing on subtle, everyday shifts in mood, focus, and creativity, he emphasized the practice of “citizen science” (public participation in scientific research to enhance knowledge).
In his latest book with Jordan Gruber, Microdosing for Healing, Health, and Enhanced Performance (2024), Fadiman shares patterns from over a decade of this citizen science. He asserts that the “reported and perceived changes in enhanced capacities and health conditions far exceed the possibility of just being explained by placebo and expectation effects.”
What the Science Says So Far: The Jury Is Still Out
Recent placebo-controlled studies have cast doubt on the pharmacological efficacy of microdosing psychedelics, suggesting that observed benefits may largely stem from participants’ expectations.
For instance, a self-blinding study involving 191 participants found that both microdose and placebo groups reported similar improvements in psychological well-being, indicating a strong placebo effect (Szigeti et al., 2021).
Skeptics of microdosing may find further confirmation in a comprehensive review of 19 placebo-controlled studies on LSD and psilocybin microdosing (Polito & Liknaitzky, 2024). The authors found that microdosing can lead to subtle changes in mood, cognition, and brain activity, but showed little consistent evidence of real-world benefits like enhanced creativity or well-being.
Enthusiasts looking at the same study might note the dose-dependent effects and measurable physiological changes as signs of genuine impact. Polito & Liknaitzky themselves identify limitations in the studies so far, since they were all short, small, and focused on healthy participants, which might not reflect real-world use. The review concludes it’s still too soon to tell and calls for longer, better-designed trials, especially in clinical populations.
These discrepancies underscore the need for further research to understand the mechanisms at play and determine the true efficacy of microdosing practices. Fortunately, a number of clinical trials are underway—and even the current findings offer insights into how belief, intention, and context influence healing.
The Placebo Effect Is Often Misunderstood
Placebo is often misunderstood as being “fake,” but neuroscience is showing otherwise. When you expect healing, your brain may release dopamine, reduce cortisol, and change how it interprets pain, mood, and emotion (Benedetti, 2014). Belief is biochemistry.
Even more curiously, placebos can work even when people know they’re taking them. Open-label placebo studies show that participants who are told they’re taking an inert pill still report real improvements. This suggests that belief, intention, and ritual may be more central to healing than we’ve assumed—and may help explain the microdosing phenomenon.
Microdosing, Meaning, and Mindset
Perhaps microdosing’s greatest gift so far is not what it “does,” but what it reflects: the power of attention, intention, and self-authorized change. For many, it provides hope after other healing methods have fallen short.
Medical anthropologist Daniel Moerman coined the term “meaning response” to describe how our interpretations of a treatment—rather than its pharmacological content—can shape its effects. In this sense, microdosing may be as much about narrative as it is about neurology.
Psychedelics Essential Reads
From choosing a substance to microdosing to journaling about intentions to tracking changes, microdosers often engage in a set of practices that signal self-care and growth. These rituals of self-communication can be powerful tools for transformation, whether or not a psychedelic is involved.
Harnessing the Power of Belief
The exploration of microdosing reveals something essential about the human capacity for self-healing. Whether through pharmacology or belief, practices like intention-setting, ritual, and self-awareness highlight the deep interplay between mind and body.
As Henry Ford famously said, “Whether you think you can, or you think you can’t—you’re right.” Belief in one’s own healing capacities may be part of what shifts someone from stuck to empowered.
Whether those changes come through serotonin receptors or narrative rituals may be beside the point. In the end, microdosing’s wisdom may not lie in the compound itself, but in how it invites us to harness the placebo effect as a tool for everyday change.
